Outcome of Long Stent Length in Paclitaxel-eluting Stents Versus Everolimus-eluting Coronary Stents in a Diabetic Population

被引:0
|
作者
Kaul, Upendra [1 ]
Arambam, Priyadarshini [2 ]
机构
[1] Fortis Flt Lt Rajan Dhall Hosp, New Delhi, India
[2] Fortis Healthcare Ltd, Gurgaon, India
关键词
D O I
10.1016/j.jacc.2017.03.197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A-151
引用
收藏
页码:S82 / S82
页数:1
相关论文
共 50 条
  • [31] Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus
    Stone, Gregg. W.
    Kedhi, Elvin
    Kereiakes, Dean J.
    Parise, Helen
    Fahy, Martin
    Serruys, Patrick W.
    Smits, Pieter C.
    [J]. CIRCULATION, 2011, 124 (08) : 893 - 900
  • [32] The Real World Experience of the Everolimus-Eluting Coronary Stent System: Audit of Everolimus-Eluting Coronary Stents
    Aldous, Sally
    Smyth, David
    Blake, James
    McClean, Dougal
    Elliott, John
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2011, 24 (03) : 241 - 246
  • [33] Paclitaxel-eluting stents versus sirolimus-eluting stents in treatment of coronary vessels
    Kate Matthews
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (5): : 236 - 236
  • [34] Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents: A Meta-Analysis of 4 Trials
    Claessen, Bimmer E.
    Stone, Gregg W.
    Smits, Pieter C.
    Kedhi, Elvin
    Kikkert, Wouter J.
    Piek, Jan J.
    Henriques, Jose P. S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B63 - B64
  • [35] Optical Coherence Tomography Analysis for Restenosis of Everolimus-Eluting Stents In Comparison with Bare-Metal Stents and Paclitaxel-Eluting Stents
    Kuramitsu, Shoichi
    Iwabuchi, Masashi
    Toyota, Fumitoshi
    Haraguchi, Takuya
    Kazuno, Yoshio
    Enomoto, Soichiro
    Mazaki, Toru
    Domei, Takenori
    Hyodo, Makoto
    Shirai, Shinichi
    Takabatake, Yoshitaka
    Yokoi, Hiroyoshi
    Nobuyoshi, Masakiyo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B181 - B181
  • [36] Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
    Shah, Rahman
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 165 (11) : 828 - 829
  • [37] Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents
    Sorrentino, Sabato
    Giustino, Gennaro
    Mehran, Roxana
    Kini, Anapoorna S.
    Sharma, Samin K.
    Faggioni, Michela
    Farhan, Serdar
    Vogel, Birgit
    Indolfi, Ciro
    Dangas, George D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (25) : 3055 - 3066
  • [38] Comparison of Everolimus-Eluting Stent With Paclitaxel-Eluting Stent in Long Chronic Total Occlusions
    Valenti, Renato
    Vergara, Ruben
    Migliorini, Angela
    Parodi, Guido
    Buonamici, Piergiovanni
    Cerisano, Giampaolo
    Carrabba, Nazario
    Antoniucci, David
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (12): : 1768 - 1771
  • [39] Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis
    Almalla, Mohammad
    Schroeder, Joerg
    Pross, Verena
    Marx, Nikolaus
    Hoffmann, Rainer
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (06) : 881 - 887
  • [40] Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans
    Otsuka, Fumiyuki
    Vorpahl, Marc
    Nakano, Masataka
    Foerst, Jason
    Newell, John B.
    Sakakura, Kenichi
    Kutys, Robert
    Ladich, Elena
    Finn, Aloke V.
    Kolodgie, Frank D.
    Virmani, Renu
    [J]. CIRCULATION, 2014, 129 (02) : 211 - 223